Selected research
Market Analysis & Forecast
Global Digital COPD Management Market Analysis and Forecast 2026-2032
Market perspective
The global Digital COPD Management market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for Digital COPD Management is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Digital COPD Management is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Digital COPD Management is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Digital COPD Management is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of Digital COPD Management include Teva Digital Health, AstraZeneca Digital Health, GSK Digital Health, Boehringer Ingelheim Digital Health, Huma Therapeutics, Biofourmis, Kaia Health, Ada Health and Current Health, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Digital COPD Management, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Digital COPD Management, also provides the revenue of main regions and countries. Of the upcoming market potential for Digital COPD Management, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Digital COPD Management revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Digital COPD Management market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Digital COPD Management revenue, projected growth trends, production technology, application and end-user industry.
Digital COPD Management Segment by Company
Teva Digital Health
AstraZeneca Digital Health
GSK Digital Health
Boehringer Ingelheim Digital Health
Huma Therapeutics
Biofourmis
Kaia Health
Ada Health
Current Health
Wellinks
Sensviv
ResMed Inc
Philips Respironics
Propeller Health
Digital COPD Management Segment by Type
Symptom Monitoring
Lung Function Management
Acute Exacerbation Prediction
Medication Adherence Management
Others
Digital COPD Management Segment by Application
Hospital Respiratory Department Management
Home Health Self-Management
Insurance-Based Health Management
Telemedicine
Digital COPD Management Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Digital COPD Management market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Digital COPD Management and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Digital COPD Management.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Digital COPD Management in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Digital COPD Management company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Digital COPD Management revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Symptom Monitoring
- Lung Function Management
- Acute Exacerbation Prediction
- Medication Adherence Management
- Others
Applications
- Hospital Respiratory Department Management
- Home Health Self-Management
- Insurance-Based Health Management
- Telemedicine
Companies covered
- Teva Digital Health
- AstraZeneca Digital Health
- GSK Digital Health
- Boehringer Ingelheim Digital Health
- Huma Therapeutics
- Biofourmis
- Kaia Health
- Ada Health
- Current Health
- Wellinks
- Sensviv
- ResMed Inc
- Philips Respironics
- Propeller Health
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Digital COPD Management Market by Type
- 1.2.1 Global Digital COPD Management Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Symptom Monitoring
- 1.2.3 Lung Function Management
- 1.2.4 Acute Exacerbation Prediction
- 1.2.5 Medication Adherence Management
- 1.2.6 Others
- 1.3 Digital COPD Management Market by Application
- 1.3.1 Global Digital COPD Management Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Hospital Respiratory Department Management
- 1.3.3 Home Health Self-Management
- 1.3.4 Insurance-Based Health Management
- 1.3.5 Telemedicine
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Digital COPD Management Market Dynamics
- 2.1 Digital COPD Management Industry Trends
- 2.2 Digital COPD Management Industry Drivers
- 2.3 Digital COPD Management Industry Opportunities and Challenges
- 2.4 Digital COPD Management Industry Restraints
3 Global Growth Perspective
- 3.1 Global Digital COPD Management Market Perspective (2021-2032)
- 3.2 Global Digital COPD Management Growth Trends by Region
- 3.2.1 Global Digital COPD Management Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Digital COPD Management Market Size by Region (2021-2026)
- 3.2.3 Global Digital COPD Management Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global Digital COPD Management Revenue by Players
- 4.1.1 Global Digital COPD Management Revenue by Players (2021-2026)
- 4.1.2 Global Digital COPD Management Revenue Market Share by Players (2021-2026)
- 4.1.3 Global Digital COPD Management Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Digital COPD Management Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global Digital COPD Management Key Players Headquarters & Area Served
- 4.4 Global Digital COPD Management Players, Product Type & Application
- 4.5 Global Digital COPD Management Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global Digital COPD Management Market CR5 and HHI
- 4.6.3 2025 Digital COPD Management Tier 1, Tier 2, and Tier 3
5 Digital COPD Management Market Size by Type
- 5.1 Global Digital COPD Management Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global Digital COPD Management Revenue by Type (2021-2032)
- 5.3 Global Digital COPD Management Revenue Market Share by Type (2021-2032)
6 Digital COPD Management Market Size by Application
- 6.1 Global Digital COPD Management Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global Digital COPD Management Revenue by Application (2021-2032)
- 6.3 Global Digital COPD Management Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 Teva Digital Health
- 7.1.1 Teva Digital Health Company Information
- 7.1.2 Teva Digital Health Business Overview
- 7.1.3 Teva Digital Health Digital COPD Management Revenue and Gross Margin (2021-2026)
- 7.1.4 Teva Digital Health Digital COPD Management Product Portfolio
- 7.1.5 Teva Digital Health Recent Developments
- 7.2 AstraZeneca Digital Health
- 7.2.1 AstraZeneca Digital Health Company Information
- 7.2.2 AstraZeneca Digital Health Business Overview
- 7.2.3 AstraZeneca Digital Health Digital COPD Management Revenue and Gross Margin (2021-2026)
- 7.2.4 AstraZeneca Digital Health Digital COPD Management Product Portfolio
- 7.2.5 AstraZeneca Digital Health Recent Developments
- 7.3 GSK Digital Health
- 7.3.1 GSK Digital Health Company Information
- 7.3.2 GSK Digital Health Business Overview
- 7.3.3 GSK Digital Health Digital COPD Management Revenue and Gross Margin (2021-2026)
- 7.3.4 GSK Digital Health Digital COPD Management Product Portfolio
- 7.3.5 GSK Digital Health Recent Developments
- 7.4 Boehringer Ingelheim Digital Health
- 7.4.1 Boehringer Ingelheim Digital Health Company Information
- 7.4.2 Boehringer Ingelheim Digital Health Business Overview
- 7.4.3 Boehringer Ingelheim Digital Health Digital COPD Management Revenue and Gross Margin (2021-2026)
- 7.4.4 Boehringer Ingelheim Digital Health Digital COPD Management Product Portfolio
- 7.4.5 Boehringer Ingelheim Digital Health Recent Developments
- 7.5 Huma Therapeutics
- 7.5.1 Huma Therapeutics Company Information
- 7.5.2 Huma Therapeutics Business Overview
- 7.5.3 Huma Therapeutics Digital COPD Management Revenue and Gross Margin (2021-2026)
- 7.5.4 Huma Therapeutics Digital COPD Management Product Portfolio
- 7.5.5 Huma Therapeutics Recent Developments
- 7.6 Biofourmis
- 7.6.1 Biofourmis Company Information
- 7.6.2 Biofourmis Business Overview
- 7.6.3 Biofourmis Digital COPD Management Revenue and Gross Margin (2021-2026)
- 7.6.4 Biofourmis Digital COPD Management Product Portfolio
- 7.6.5 Biofourmis Recent Developments
- 7.7 Kaia Health
- 7.7.1 Kaia Health Company Information
- 7.7.2 Kaia Health Business Overview
- 7.7.3 Kaia Health Digital COPD Management Revenue and Gross Margin (2021-2026)
- 7.7.4 Kaia Health Digital COPD Management Product Portfolio
- 7.7.5 Kaia Health Recent Developments
- 7.8 Ada Health
- 7.8.1 Ada Health Company Information
- 7.8.2 Ada Health Business Overview
- 7.8.3 Ada Health Digital COPD Management Revenue and Gross Margin (2021-2026)
- 7.8.4 Ada Health Digital COPD Management Product Portfolio
- 7.8.5 Ada Health Recent Developments
- 7.9 Current Health
- 7.9.1 Current Health Company Information
- 7.9.2 Current Health Business Overview
- 7.9.3 Current Health Digital COPD Management Revenue and Gross Margin (2021-2026)
- 7.9.4 Current Health Digital COPD Management Product Portfolio
- 7.9.5 Current Health Recent Developments
- 7.10 Wellinks
- 7.10.1 Wellinks Company Information
- 7.10.2 Wellinks Business Overview
- 7.10.3 Wellinks Digital COPD Management Revenue and Gross Margin (2021-2026)
- 7.10.4 Wellinks Digital COPD Management Product Portfolio
- 7.10.5 Wellinks Recent Developments
- 7.11 Sensviv
- 7.11.1 Sensviv Company Information
- 7.11.2 Sensviv Business Overview
- 7.11.3 Sensviv Digital COPD Management Revenue and Gross Margin (2021-2026)
- 7.11.4 Sensviv Digital COPD Management Product Portfolio
- 7.11.5 Sensviv Recent Developments
- 7.12 ResMed Inc
- 7.12.1 ResMed Inc Company Information
- 7.12.2 ResMed Inc Business Overview
- 7.12.3 ResMed Inc Digital COPD Management Revenue and Gross Margin (2021-2026)
- 7.12.4 ResMed Inc Digital COPD Management Product Portfolio
- 7.12.5 ResMed Inc Recent Developments
- 7.13 Philips Respironics
- 7.13.1 Philips Respironics Company Information
- 7.13.2 Philips Respironics Business Overview
- 7.13.3 Philips Respironics Digital COPD Management Revenue and Gross Margin (2021-2026)
- 7.13.4 Philips Respironics Digital COPD Management Product Portfolio
- 7.13.5 Philips Respironics Recent Developments
- 7.14 Propeller Health
- 7.14.1 Propeller Health Company Information
- 7.14.2 Propeller Health Business Overview
- 7.14.3 Propeller Health Digital COPD Management Revenue and Gross Margin (2021-2026)
- 7.14.4 Propeller Health Digital COPD Management Product Portfolio
- 7.14.5 Propeller Health Recent Developments
8 North America
- 8.1 North America Digital COPD Management Revenue (2021-2032)
- 8.2 North America Digital COPD Management Revenue by Type (2021-2032)
- 8.2.1 North America Digital COPD Management Revenue by Type (2021-2026)
- 8.2.2 North America Digital COPD Management Revenue by Type (2027-2032)
- 8.3 North America Digital COPD Management Revenue Share by Type (2021-2032)
- 8.4 North America Digital COPD Management Revenue by Application (2021-2032)
- 8.4.1 North America Digital COPD Management Revenue by Application (2021-2026)
- 8.4.2 North America Digital COPD Management Revenue by Application (2027-2032)
- 8.5 North America Digital COPD Management Revenue Share by Application (2021-2032)
- 8.6 North America Digital COPD Management Revenue by Country
- 8.6.1 North America Digital COPD Management Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America Digital COPD Management Revenue by Country (2021-2026)
- 8.6.3 North America Digital COPD Management Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe Digital COPD Management Revenue (2021-2032)
- 9.2 Europe Digital COPD Management Revenue by Type (2021-2032)
- 9.2.1 Europe Digital COPD Management Revenue by Type (2021-2026)
- 9.2.2 Europe Digital COPD Management Revenue by Type (2027-2032)
- 9.3 Europe Digital COPD Management Revenue Share by Type (2021-2032)
- 9.4 Europe Digital COPD Management Revenue by Application (2021-2032)
- 9.4.1 Europe Digital COPD Management Revenue by Application (2021-2026)
- 9.4.2 Europe Digital COPD Management Revenue by Application (2027-2032)
- 9.5 Europe Digital COPD Management Revenue Share by Application (2021-2032)
- 9.6 Europe Digital COPD Management Revenue by Country
- 9.6.1 Europe Digital COPD Management Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe Digital COPD Management Revenue by Country (2021-2026)
- 9.6.3 Europe Digital COPD Management Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China Digital COPD Management Revenue (2021-2032)
- 10.2 China Digital COPD Management Revenue by Type (2021-2032)
- 10.2.1 China Digital COPD Management Revenue by Type (2021-2026)
- 10.2.2 China Digital COPD Management Revenue by Type (2027-2032)
- 10.3 China Digital COPD Management Revenue Share by Type (2021-2032)
- 10.4 China Digital COPD Management Revenue by Application (2021-2032)
- 10.4.1 China Digital COPD Management Revenue by Application (2021-2026)
- 10.4.2 China Digital COPD Management Revenue by Application (2027-2032)
- 10.5 China Digital COPD Management Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Digital COPD Management Revenue (2021-2032)
- 11.2 Asia Digital COPD Management Revenue by Type (2021-2032)
- 11.2.1 Asia Digital COPD Management Revenue by Type (2021-2026)
- 11.2.2 Asia Digital COPD Management Revenue by Type (2027-2032)
- 11.3 Asia Digital COPD Management Revenue Share by Type (2021-2032)
- 11.4 Asia Digital COPD Management Revenue by Application (2021-2032)
- 11.4.1 Asia Digital COPD Management Revenue by Application (2021-2026)
- 11.4.2 Asia Digital COPD Management Revenue by Application (2027-2032)
- 11.5 Asia Digital COPD Management Revenue Share by Application (2021-2032)
- 11.6 Asia Digital COPD Management Revenue by Country
- 11.6.1 Asia Digital COPD Management Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia Digital COPD Management Revenue by Country (2021-2026)
- 11.6.3 Asia Digital COPD Management Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Digital COPD Management Revenue (2021-2032)
- 12.2 SAMEA Digital COPD Management Revenue by Type (2021-2032)
- 12.2.1 SAMEA Digital COPD Management Revenue by Type (2021-2026)
- 12.2.2 SAMEA Digital COPD Management Revenue by Type (2027-2032)
- 12.3 SAMEA Digital COPD Management Revenue Share by Type (2021-2032)
- 12.4 SAMEA Digital COPD Management Revenue by Application (2021-2032)
- 12.4.1 SAMEA Digital COPD Management Revenue by Application (2021-2026)
- 12.4.2 SAMEA Digital COPD Management Revenue by Application (2027-2032)
- 12.5 SAMEA Digital COPD Management Revenue Share by Application (2021-2032)
- 12.6 SAMEA Digital COPD Management Revenue by Country
- 12.6.1 SAMEA Digital COPD Management Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA Digital COPD Management Revenue by Country (2021-2026)
- 12.6.3 SAMEA Digital COPD Management Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst